How Many Tests Need to Be Performed to Know That a Batch of Pills is Safe?

Testing medicine for legitimacy is a complicated process. Across 24 different prescription medicines, the average cost to test a single dose is $2,750. However, ensuring that a batch of 100 pills is 90% certain to be safe requires testing at least 22 pills. Achieving 99.999% certainty requires even more testing, at tremendous expense. To learn more about this topic, read PSM’s summary: safedr.ug/Acri-Explained.

[...]

COVID-19 Scams Video Update, March 30, 2020

In this edition: Rise of Fake ‘Corona Cures’ Revealed in Global Counterfeit Medicine Operation, Fake ‘COVID-19 Testing Kits’ Across North America, FDA Letter: Do Not Use Chloroquine Phosphate Intended for Fish as Treatment for COVID-19, and L.A. Warns of Coronavirus Consumer Issues.

[...]

FDA Alert: Do Not Use Chloroquine Phosphate Intended for Fish as Treatment for COVID-19 in Humans

The FDA’s Center for Veterinary Medicine has recently become aware that some consumers may mistake chloroquine phosphate used to treat disease in aquarium fish for FDA-approved drugs (used to treat malaria and certain other conditions in humans) that are being studied as a COVID-19 treatment for humans. Unfortunately, we have learned that one person in the United States has died after he and his wife reportedly took chloroquine used to treat their fish in an attempt to prevent COVID-19; his wife also became very ill. We are continuing to investigate this incident.

[...]

Life-threatening counterfeit drugs taught Rick Roberts that medicine safety can’t be taken for granted

Rock Roberts opening the Senate briefing

Life-threatening counterfeit drugs taught Rick Roberts that medicine safety can’t be taken for granted. Safe medicines advocate Rick Roberts opening the Senate briefing, September 24, 2019. Rick Roberts, a professor at the University of San Francisco and a member of The Partnership for Safe Medicines’ Advisory Board, began thinking about the problem of medicine safety…

[...]

Executive Director of Colon Cancer Association Warns Against “Ill-Considered Drug Importation Scheme”

This editorial by Andrew Spiegel was published in The International Business Times on March 23, 2020. Mr. Spiegel is executive director of the Global Colon Cancer Association and Chair of the World Patient Alliance. President Trump, Price Controls Can’t Combat Coronavirus The U.S. outbreak of novel coronavirus, COVID-19, has quickly evolved into a national nightmare.…

[...]